Dysbiosis-Mediated Regulation of Stem Cells the First Hit for Cancer Generation

Human microbiota, a complex consortium of microorganisms co-evolved with the host, profoundly influences tissue development, immune regulation, and disease progression. Growing evidence shows that microbial metabolites and signaling molecules modulate key stem cell pathways-such as <i>Hedgehog</i>, <i>Wnt/β-catenin</i>, and <i>Notch</i>-thereby reprogramming stem cell fate toward tumor-suppressive or tumor-promoting outcomes. Specific taxa within oral, intestinal, and urogenital niches have been linked to cancer initiation, therapy resistance, and recurrence. In parallel, clinical studies reveal that microbiota composition affects infection dynamics: bacterial isolates from symptomatic urinary tract infections inhibit commensal growth more strongly than the reverse, with Gram-positive and Gram-negative strains displaying distinct interaction profiles. Collectively, these findings highlight microbiota's dual role in regulating cellular plasticity and pathogenicity. Elucidating host-microbe and microbe-microbe mechanisms may guide microbiota-targeted interventions to improve cancer and infectious disease management.